Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Cysview is an optical imaging agent designed to enhance detection of bladder cancer, in particular carcinoma in situ (CIS), it reveals lesions that may not be seen with standard white light cystoscopy. Cysview is marketed in Europe as Hexvix. Cysview is licensed by GE Healthcare from Photocure ASA a Norwegian pharmaceutical company that develops and sells pharmaceuticals and medical devices for the photodynamic treatment and diagnosis of cancer and selected dermatology indications.
Bitte wählen Sie Ihr Anliegen aus.
Rechnungen
Retourenschein anfordern
Bestellstatus
Storno